Back to search
Dysplastic Barrett's Esophagus
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Dysplastic Barrett's Esophagus trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Dysplastic Barrett's Esophagus trials you may qualify forPrevious studies have confirmed the great potential of quantitative fluorescence molecular endoscopy (qFME) when looking at additional lesion detection initiall…
Patients undergoing ablative therapy for management of dysplastic Barrett's Esophagus (BE) will have decreased distensibility over the course of treatment, but…
The purpose of this study is to create a registry (collect data and keep it in a research database) to learn more about two methods of taking small tissue sampl…
This clinical trial evaluates the use of cytosponge, a minimally invasive collection device, for the detection of Barrett's esophagus (BE) in patients undergoin…
The purpose of this study is to learn the best approach to treating patients with known or suspected Barrett's esophagus by comparing endoscopic surveillance to…
This research study is creating a way to collect and store specimens and information from participants who may be at an increased risk of developing cancer, or…
This study explores the use of a minimally invasive screening tool (a sponge on a string device) to detect Barrett's esophagus and esophageal adenocarcinoma and…
The aim of the clinical trial is to evaluate the EndoRotor®'s ability to completely remove areas of Barrett's esophagus considered refractory after 3 failed abl…